Funding (as of November 4th, 2013)


Active Funding

NIH/NCI
Title: “Discovery of novel thiazole compounds for treating advanced melanoma”

PI: 1R21AR063242-01A1, MPI: Wei Li (NIH contact); Duane Miller
NIH/NIAMS
Title: “Discovery of tissue-selective, nonhypercalcemic VDR modulators for RA treatment”
4/1/2013-3/31/2015
Total two year direct cost: $233,750, total cost: $350,625

Co-I: 1R01AR056666-01A2 (PI: Andrzej T. Slominski)
NIH
Title: “Role of exogenous melatonin in skin biology”
08/01/2011-07/31/2016
Estimated five year total: $1,662,408.
Role: Co-investigator

Co-I: 2R01AR052190-06A1 (PI: Andrzej Slominski)
NIH/NIAMS
Title: “Novel Biosynthethic Pathway for Secosteroids and the Skin”
10/2013-9/2014
Direct cost: $200,000, total cost: $300,000 for the year.
Role: Co-investigator

Co-I: 2014 West Cancer Center Research Support Award (PI: Andrzej Slominski)
Title: “Pre-clinical testing of anti-melanoma activity of 20-hydroxyvitamin D3”
1/1/2014-21/31/2014  
Direct cost: $50,000, no indirect cost.
The goal of this project is to test in vivo anti-melanoma activity of novel non-calcemic analogs of vitamin D.
Role: Co-I

COMPLETED SUPPORT

PI: UTHSC Contract# 8500035962
Source: Private Company
Title: “UPLC/UV analysis of active components in sunscreen samples”
10/2013-12/2013
Service Contract: $4,415 to UTHSC

PI: 1S10OD010678-01
NIH
Title: “Acquisition of a Q-TOF Mass Spectrometer”
05/01/2012-04/30/2013
Direct cost: $325,000, equipment grant, no indirect cost allowed by NIH

PI: 2012 Dean’s Research Enhancement Program
UTHSC College of Pharmacy (Internal funding)
Title: “Mechanistic and in vivo efficacy studies against breast tumors using a novel HIF-1alpha inhibitor”
11/2012-6/2013
Amount: $15,000

Co-I: 2012 Dean’s Research Enhancement Program (PI: Bob Moore)
UTHSC College of Pharmacy (Internal funding)
Title: “Acquisition of a Meso Scale Discovery SECTOR Imager 2400”
11/2012-6/2013
Amount: $35,000
Role: Co-investigator

Co-I: 1RO1 AR052190-01A2 (PI: Andrzej T. Slominski)
NIH
Title: “Novel Biosynthetic Pathway for Secosteroids and the Skin”
08/2006-07/2012
Five year total award amount: $1,922,190

PI: Dean’s Enhancement Program for Research Equipment
College of Pharmacy, University of Tennessee Health Science Center (UTHSC internal fund)
Title: “Purchase of an inverted fluorescence microscope”
05/2012-06/2012
Total cost: $15,000

PI: Pilot Study to Assess Blood Chemistry at High Dose 20S/R-OH-D3 in Mice
University of Tennessee Research Foundation
03/2012-06/2012
Total cost: $3,000.

PI: RR-026377-01
NIH/NCRR
Title: "Acquistion of a 400M NMR with an autosampler"
08/23/2010-08/22/2011
Total direct: $252,900, total amount: $252,900, equipment grant, no indirect cost allowed by NIH.

PI: 1R15CA125623-01A2
National Cancer Institute, NIH
Title: “Discovery of Novel Cytotoxic Agents for Advanced Melanoma”
3/2008 – 2/2011.
Total direct: $150,000, total amount: $219,000

PI: Technology Maturation Award
University of Tennessee Research Foundation, University of Tennessee
Title “In vivo Assessment of Efficacy of Novel Thiazole Compounds”
2/2009-10/2009
Total direct: $15,000; Total amount: $15,000.

PI: College of Pharmacy Seed Research Fund
University of Tennessee
Title: “Development of Novel Cytotoxic Agents towards Advanced Melanoma”
2006-2007
Total direct: $9,300; total amount: $9,300

Co-I: 1R03AI054798-01 (PI: Richard Lee)
NIH/NIAID
Title: “Whole Cell NMR Studies of MYcobacteria”
05/2003-12/2006
Total direct: $100,000; Total amount: $146,000

Co-I: DAMD17-01-0830 (PI: Duane Miller)
Department of Defense
Title: “Selective Cytotoxic Phospholipids for Prostate Cancer”
9/20/2001-10/20/2005
Total cost: $556,364
Role: Investigator

College of Pharmacy, faculty start-up fund for Dr. Wei Li, 2004-2007.